Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells

BACKGROUND: Drug repurposing enables the discovery of potential cancer treatments using publically available data from over 4000 published Food and Drug Administration approved and experimental drugs. However, the ability to effectively evaluate the drug's efficacy remains a challenge. Impedime...

Descripción completa

Detalles Bibliográficos
Autores principales: Naeem, Aisha, Dakshanamurthy, Sivanesan, Walthieu, Henry, Parasido, Erika, Avantaggiati, Maria, Tricoli, Lucas, Kumar, Deepak, Lee, Richard J., Feldman, Adam, Noon, Muhammad S., Byers, Stephen, Rodriguez, Olga, Albanese, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540414/
https://www.ncbi.nlm.nih.gov/pubmed/32761925
http://dx.doi.org/10.1002/pros.24050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540414/
https://www.ncbi.nlm.nih.gov/pubmed/32761925
http://dx.doi.org/10.1002/pros.24050

Ejemplares similares